Ayala Pharmaceuticals, Inc.
ADXSOTCHealthcare
$0.60
+$0.00(+0.00%)
Market Cap$25707577
P/E Ratio—
52W High$0.801
52W Low$0.0011
Ayala Pharmaceuticals, Inc. (ADXS) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ADXS · as of 2026-06-15
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2023-12 | 2022-12 | 2022-01 | 2021-01 | 2020-01 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $4.88M | $25.21M | $41.61M | $25.18M | $16.73M |
| Net Receivables | $0.00M | $0.23M | $0.68M | $0.47M | $0.47M |
| Inventory | $0.00M | ($0.23M) | ($0.68M) | $1.34M | $0.08M |
| Total Current Assets | $7.53M | $25.76M | $43.26M | $27.85M | $17.69M |
| PP&E Net | $0.64M | $0.05M | $0.16M | $7.23M | $1.42M |
| Goodwill | $4.50M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $3.90M | $0.11M | $3.35M | $3.26M | $4.58M |
| Total Assets | $16.58M | $25.93M | $46.78M | $38.53M | $20.05M |
| Liabilities | |||||
| Short-Term Debt | $0.17M | $0.01M | $0.03M | $0.96M | $0.00M |
| Accounts Payable | $6.08M | $0.02M | $2.25M | $1.08M | $2.92M |
| Total Current Liabilities | $25.02M | $2.30M | $7.88M | $3.29M | $5.30M |
| Long-Term Debt | $8.15M | $1.33M | $0.01M | $5.05M | $0.30M |
| Total Liabilities | $41.00M | $2.30M | $7.89M | $8.35M | $5.60M |
| Stockholders Equity | |||||
| Retained Earnings | ($197.23M) | ($442.96M) | ($428.60M) | ($410.74M) | ($40.74M) |
| Total Stockholders Equity | ($24.42M) | $23.63M | $38.89M | $30.18M | $14.45M |
| Total Liab & Equity(computed) | $16.58M | $25.93M | $46.78M | $38.53M | $20.05M |
| Debt Summary | |||||
| Total Debt | $8.32M | $0.01M | $0.04M | $6.02M | $0.30M |
| Net Debt | $3.43M | ($25.20M) | ($41.57M) | ($19.16M) | ($16.43M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · USD · M
Explore more Ayala Pharmaceuticals, Inc. data
About Ayala Pharmaceuticals, Inc. (ADXS) Balance Sheet
Ayala Pharmaceuticals, Inc. (ADXS) balance sheet shows total assets of $0.02B with cash of $0.00B. Total liabilities are $0.04B, total debt $0.01B, and stockholders equity ($0.02B).
Frequently asked questions
ADXS · 4 questionsAyala Pharmaceuticals, Inc. has total debt of $0.01B with net debt of $0.00B.
ADXS total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15